EUROPE BOTULINUM TOXIN MARKET FORECAST 2021-2028

The Europe botulinum toxin market is estimated to register a CAGR of 5.16% during the forecast period of 2021 to 2028. Chief factors such as the moderate impact of regulations and the increasing demand for non-invasive procedures from western Europe, as well as the rising interest from Eastern European nations, are set to supplement the market growth of the region.

europe-botulinum-toxin-market

The Europe botulinum toxin market growth assessment includes analyzing Belgium, Germany, Poland, Russia, the United Kingdom, Italy, France, and the rest of Europe. The United Kingdom is well-recognized for aesthetic procedures, including non-surgical and surgical cosmetic treatments. The country’s botulinum toxin market continues to observe rapid growth, owing to the increasing acceptance of botulinum toxin, in addition to the rising number of product approvals. According to an article published by the British Association of Aesthetic Plastic Surgeons (BAAPS) in 2019, the demand for non-surgical treatments in the United Kingdom is on the rise.

On the other hand, cosmetic surgeries witness a growing trend in Germany since they help enhance an individual’s physical appearance. Furthermore, aesthetic clinics in the country are ranked among the leading positions worldwide. The extensive experience of German specialists and innovative technologies have also played an essential role by generating significant results, thereby facilitating a high demand for botulinum toxin. Hence, these drives are expected to propel the market growth in Europe over the forecasted years.

Allergan PLC, headquartered in Ireland, is an international pharmaceutical company with operations in over 100 nations. It is predominantly focused on manufacturing, developing, and commercializing branded pharmaceutical devices, in addition to surgical, biological, and regenerative medicine products for patients globally. The company’s portfolio constitutes products catering to eye care, the central nervous system, gastroenterology, anti-infective therapeutic, medical aesthetics and dermatology, urology, and women’s health.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. RELATED MARKET ANALYSIS: AESTHETIC FILLER MARKET
    2. KEY DRIVERS
      1. INCREASING DEMAND FOR AESTHETIC PROCEDURES
      2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
    3. KEY RESTRAINTS
      1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
      2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
      3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY TYPE
    1. TYPE A
    2. TYPE B
  6. MARKET BY APPLICATION
    1. COSMETIC APPLICATIONS
      1. GLABELLAR LINES
      2. LATERAL CANTHAL LINES (CROW’S FEET)
      3. FOREHEAD LINES
      4. OTHER COSMETIC APPLICATIONS
    2. NON-COSMETIC APPLICATIONS
      1. DYSTONIA
      2. CHRONIC MIGRAINE
      3. OPHTHALMOLOGIC DISORDERS
      4. OTHER NON-COSMETIC APPLICATIONS
  7. MARKET BY END-USER
    1. HOSPITALS
    2. CLINICS AND OTHERS
  8. GEOGRAPHICAL ANALYSIS
    1. EUROPE
      1. KEY GROWTH ENABLERS
      2. KEY CHALLENGES
      3. KEY PLAYERS
      4. COUNTRY ANALYSIS
        1. UNITED KINGDOM    
        2. GERMANY      
        3. FRANCE          
        4. ITALY    
        5. RUSSIA
        6. BELGIUM         
        7. POLAND          
        8. REST OF EUROPE               
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. PRODUCT LAUNCHES & DEVELOPMENTS
    2. COMPANY PROFILES
      1. ABBVIE INC (ALLERGAN PLC)
      2. EVOLUS INC
      3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
      4. HUGEL INC
      5. IPSEN PHARMA
      6. MEDYTOX INC
      7. MERZ PHARMA
      8. REVANCE THERAPEUTICS INC
      9. US WORLDMEDS LLC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN

TABLE 2: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020

FIGURE 6: EUROPE BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

FIGURE 9: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

FIGURE 20: EUROPE BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 21: EUROPE BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 22: EUROPE BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 23: UNITED KINGDOM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 24: GERMANY BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 25: FRANCE BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: ITALY BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: RUSSIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: BELGIUM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: POLAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: REST OF EUROPE BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample